According to a new report by IMARC Group, the global blood culture test market exhibited strong growth during 2015-2020. Looking forward, the market expects to grow at a CAGR of around 9% during 2021-2026.
A blood culture test is used to check foreign invaders like yeast, bacteria, and other microorganisms in the blood. It relies on the blood sample of an individual obtained via sterile technique, which is kept in culture media and incubated in a controlled environment for a few days. the results help in determining the pathogens causing the infection and possible methods for combating the disease.
Global Blood Culture Test Market Trends
The global market is primarily driven by the rising incidences of bloodstream infections (BSI), sepsis and environment-borne diseases. Besides this, the increasing prevalence of chronic diseases, especially among the geriatric population, which is relatively more prone to medical ailments, is also contributing to the market growth. Furthermore, leading players are focusing on launching novel diagnostic techniques to reduce diagnosis time, eliminate manual errors and offer early prevention of infections. This, along with the rising cases of coronavirus disease (COVID-19), is escalating the demand for blood culture tests, thereby supporting the market growth.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Global Blood Culture Test Market 2021-2026 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories (ABT)
- Beckman Coulter ( BEC )
- BD (Becton, Dickinson and Company) (NYSE:BDX)
- BIOMERIEUX (BIM.PA)
- Bruker Corporation (BRKR)
- Cepheid (NASDAQ:CPHD). (Danaher Corporation)
- Luminex Corporation
- Merck Group
- Siemens Healthineers AG
- Roche Diagnostics
- T2 Biosystems, Inc. (TTOO)
- Thermo Fisher Scientific Inc. (NYSE: TMO)
For more information about this report visit: https://www.imarcgroup.com/blood-culture-test-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800